StockData
PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Pulsenmore Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026
$1.78−0.09 (-4.81%)

Close on Oct 19, 2026

Pulsenmore statistics

Financials through Dec 31, 2025, price-based ratios appear once a share price is available

Valuation

Market Cap35.82M ILS
Enterprise Value14.21M ILS
PE Ratio2.24
PS Ratio0.89

Enterprise value

EV / Sales0.36

Income (trailing twelve months)

Revenue40.02M ILS
Gross Profit33.68M ILS
Pretax Income-15.85M ILS
EBITDA-5.82M ILS
EPS (Diluted)2.46 ILS

Margins

Gross Margin84.2%
Pretax Margin-39.6%
EBITDA Margin-14.5%
FCF Margin-82.5%

Growth

Revenue Growth (YoY)314.3%
EPS Growth (YoY)-57.3%

Balance sheet

Cash & Short-Term Investments21.60M ILS
Net Cash (Debt)21.60M ILS
Net Cash Per Share3.32 ILS
Working Capital71.07M ILS

Financial position

Current Ratio7.88
Quick Ratio2.09

Cash flow (trailing twelve months)

Operating Cash Flow-32.88M ILS
Capital Expenditures-135.00K ILS
Free Cash Flow-33.01M ILS
FCF Per Share-5.08 ILS

Efficiency

Asset Turnover0.33
Inventory Turnover0.29
Revenue Per Employee635.30K ILS
Employee Count63

Dividends and yields

FCF Yield-92.2%

Shares

Shares Outstanding6,502,840
Shares Change (YoY)0.59%
Float4,487,880
Shares Held by Insiders31.0%

Taxes

Income Tax1.00K ILS

Scores

Altman Z-Score-0.14

Calculated by StockData from Pulsenmore's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.